Nomura lowered the target price for Sino Biopharm (01177) to HKD8.67 from HKD9.17 and maintained the "buy" rating.
The research house said it fine-tunes FY26F/FY27F topline by 1.9%/-1.6% and cuts earnings estimates by 2.8%/7.3%.
【香港好去處】2026去邊最好玩?etnet為你提供全港最齊盛事活動,所有資訊盡在掌握!► 即睇

























